Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 158.38 million. The enterprise value is 154.83 million.

Market Cap	158.38M
Enterprise Value	154.83M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Medclair AB has 82.49 million shares outstanding. The number of shares has decreased by -4.21% in one year.

Current Share Class	82.49M
Shares Outstanding	82.49M
Shares Change (YoY)	-4.21%
Shares Change (QoQ)	+51.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 43.85.

PE Ratio	43.85
Forward PE	n/a
PS Ratio	3.96
PB Ratio	2.99
P/TBV Ratio	8.15
P/FCF Ratio	54.15
P/OCF Ratio	31.92
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.08, with an EV/FCF ratio of 52.93.

EV / Earnings	44.75
EV / Sales	3.87
EV / EBITDA	62.08
EV / EBIT	n/a
EV / FCF	52.93

Financial Position

The company has a current ratio of 2.46

Current Ratio	2.46
Quick Ratio	1.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.30

Financial Efficiency

Return on equity (ROE) is 6.73% and return on invested capital (ROIC) is -2.42%.

Return on Equity (ROE)	6.73%
Return on Assets (ROA)	-2.01%
Return on Invested Capital (ROIC)	-2.42%
Return on Capital Employed (ROCE)	-3.76%
Revenue Per Employee	2.86M
Profits Per Employee	247,143
Employee Count	14
Asset Turnover	0.65
Inventory Turnover	1.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.11% in the last 52 weeks. The beta is 0.67, so Medclair AB's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+71.11%
50-Day Moving Average	1.66
200-Day Moving Average	1.58
Relative Strength Index (RSI)	64.65
Average Volume (20 Days)	124,952

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 40.00 million and earned 3.46 million in profits. Earnings per share was 0.04.

Revenue	40.00M
Gross Profit	27.32M
Operating Income	-1.99M
Pretax Income	3.46M
Net Income	3.46M
EBITDA	2.49M
EBIT	-1.99M
Earnings Per Share (EPS)	0.04

Full Income Statement

Balance Sheet

The company has 3.56 million in cash and n/a in debt, giving a net cash position of 3.56 million or 0.04 per share.

Cash & Cash Equivalents	3.56M
Total Debt	n/a
Net Cash	3.56M
Net Cash Per Share	0.04
Equity (Book Value)	52.99M
Book Value Per Share	0.67
Working Capital	12.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.96 million and capital expenditures -2.04 million, giving a free cash flow of 2.93 million.

Operating Cash Flow	4.96M
Capital Expenditures	-2.04M
Free Cash Flow	2.93M
FCF Per Share	0.04

Full Cash Flow Statement

Margins

Gross margin is 68.30%, with operating and profit margins of -4.98% and 8.65%.

Gross Margin	68.30%
Operating Margin	-4.98%
Pretax Margin	8.65%
Profit Margin	8.65%
EBITDA Margin	6.23%
EBIT Margin	-4.98%
FCF Margin	7.31%

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.21%
Shareholder Yield	4.21%
Earnings Yield	2.18%
FCF Yield	1.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medclair AB has an Altman Z-Score of 9.44 and a Piotroski F-Score of 5.

Altman Z-Score	9.44
Piotroski F-Score	5